Flora Growth Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FLGC research report →
Companywww.floragrowth.com
Flora Growth Corp. , together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements; and designs and markets loungewear made from hemp-derived fabric and materials.
- CEO
- Daniel Reis-Faria
- IPO
- 2021
- Employees
- 64
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $4.23M
- P/E
- -0.27
- P/S
- 0.11
- P/B
- 1.14
- EV/EBITDA
- -0.54
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -0.10%
- Op Margin
- -27.94%
- Net Margin
- -378.02%
- ROE
- -353.13%
- ROIC
- -28.49%
Growth & Income
- Revenue
- $14.50M · -75.63%
- Net Income
- $-4,425,000 · 72.18%
- EPS
- $0.00 · 100.00%
- Op Income
- $-4,457,000
- FCF YoY
- -70.40%
Performance & Tape
- 52W High
- $47.00
- 52W Low
- $5.86
- 50D MA
- $7.86
- 200D MA
- $18.24
- Beta
- 1.90
- Avg Volume
- 96.64K
Get TickerSpark's AI analysis on FLGC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our FLGC Coverage
We haven't published any research on FLGC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate FLGC Report →